Skip to content
Trial Eligibility
Menu

Prostate Cancer Clinical Trials near Dallas, TX

51 studies for Prostate Cancer are recruiting at 89 sites within 50 miles of Dallas, Texas, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Prostate Cancer trials in the US or all trials near Dallas.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Prostate Cancer studies enrolling near Dallas

Showing the 50 nearest of 51 studies.
  1. This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

    NCT07028853

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: University of Texas Southwestern Medical Center (Dallas, TX); University of Texas Southwestern Medical Center - Simmons Cancer Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  2. Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

    NCT04423211

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Parkland Memorial Hospital (Dallas, TX); UT Southwestern Simmons Cancer Center - RedBird (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  3. Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

    NCT03678025

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Parkland Memorial Hospital (Dallas, TX); UT Southwestern Simmons Cancer Center - RedBird (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  4. Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

    NCT06632977

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Parkland Memorial Hospital (Dallas, TX); UT Southwestern Simmons Cancer Center - RedBird (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  5. Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

    NCT03866382

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: UT Southwestern Simmons Cancer Center - RedBird (Dallas, TX); UT Southwestern/Simmons Cancer Center-Dallas (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  6. Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

    NCT06931340

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: UT Southwestern Simmons Cancer Center - RedBird (Dallas, TX); UT Southwestern/Simmons Cancer Center-Dallas (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  7. Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    NCT05176483

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Exelixis Clinical Site #89 (Dallas, TX); Exelixis Clinical Site #73 (Irving, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  8. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

    NCT04585750

    • Phase 1/2
    • Ages 12 years and older
    • Sex: All

    Nearest sites: UT Southwest Simmons Cancer Center (Dallas, TX); Texas Oncology (Bedford, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  9. Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

    NCT05519449

    • Phase 1
    • Ages 18 to 100 years
    • Sex: Male

    Nearest sites: Mary Crowley Cancer Research (Dallas, TX); University of Texas Southwestern Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  10. Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

    NCT06056830

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: University of Texas Southwestern Medical Center (Dallas, TX); Urology Clinics of North Texas (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  11. A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

    NCT06778863

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Baylor University Medical Center (Dallas, TX); Mary Crowley Cancer Research (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  12. A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

    NCT06925737

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Parkland Health & Hospital System ( Site 0069) (Dallas, TX); UT Southwestern Medical Center ( Site 0039) (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  13. Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

    NCT07080242

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: NEXT Dallas (Dallas, TX); START Dallas- Fort Worth (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  14. A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

    NCT07213674

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: University of Texas Southwestern Medical Center (Dallas, TX); The Center for Cancer and Blood Disorders (Arlington, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  15. A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

    NCT07540572

    • Phase 1
    • Ages 18 to 99 years
    • Sex: All

    Nearest sites: NEXT Texas LLC - Dallas (Dallas, TX); START Dallas Fort Worth, LLC (Fort Worth, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  16. A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

    NCT07723248

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Urology Clinics Of North Texas (Dallas, TX); Urology Partners of North Texas (UPNT) (Fort Worth, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  17. Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy

    NCT02064673

    • Phase 3
    • Ages 30 to 80 years
    • Sex: Male

    Nearest site: UT Southwestern Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest site: Massive Bio SYNERGY-AI site (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance

    NCT03769766

    • Phase 3
    • Ages 40 to 89 years
    • Sex: Male

    Nearest site: UT Southwestern Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

    NCT04373564

    • Phase 4
    • Ages 18 to 64 years
    • Sex: All

    Nearest site: UT Southwestern Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

    NCT04729114

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Urology Clinics of North Texas (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. Customized TULSA-PRO Ablation Registry

    NCT05001477

    • Observational
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of Texas Southwestern Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. Study of ORIC-944 in Patients With Metastatic Prostate Cancer

    NCT05413421

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Urology Clinics of North Texas (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. Outcomes of Focal Ablation for Prostate Cancer

    NCT05478694

    • Observational
    • Ages 18 to 90 years
    • Sex: Male

    Nearest site: UTSW (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

    NCT05726292

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of Texas Southwestern Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

    NCT05803941

    • Phase 4
    • Ages 18 to 100 years
    • Sex: Male

    Nearest site: Univ of Texas Southwest Med Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

    NCT05914116

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Research Site 120 (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

    NCT05939414

    • Phase 3
    • Ages 18 to 100 years
    • Sex: Male

    Nearest site: Univ of Texas Southwest Med Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. PSMA PET Response Guided SabR in High Risk Pca

    NCT06044857

    • Phase 1
    • Ages 18 to 99 years
    • Sex: Male

    Nearest site: University of Texas Southwestern Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

    NCT06136650

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Texas Oncology - DFW ( Site 8001) (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1

    NCT06353321

    • Observational
    • Ages Any age
    • Sex: Male

    Nearest site: Ut Southwestern Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

    NCT06592924

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Dallas VA Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

    NCT06780670

    • Phase 2/3
    • Ages 18 to 100 years
    • Sex: Male

    Nearest site: Texas Oncology (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

    NCT06785636

    • Phase 1/2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of Texas Southwestern Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

    NCT06842498

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of Texas Southwestern Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

    NCT06999187

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Dren Investigational Site (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. DESTINY-PANTUMOUR04

    NCT07124000

    • Observational
    • Ages 18 to 130 years
    • Sex: All

    Nearest site: Research Site (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

    NCT07164443

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest site: UT Southwestern Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

    NCT07225946

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: UT Southwestern Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  40. Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER)

    NCT07313241

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: UT Southwestern Medical Center-Dallas (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

    NCT07488923

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: UT Southwestern Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  42. Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer

    NCT07545811

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: SCRI at Mary Crowley (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  43. A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer

    NCT07570979

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Mary Crowley Cancer Research (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  44. A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

    NCT07503808

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: NEXT Texas LLC - Dallas (Irving, TX); START Dallas Fort Worth, LLC (Fort Worth, TX)

    Distance to nearest recruiting site
    ~9 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  45. A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

    NCT03460977

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: NEXT Dallas (Irving, TX)

    Distance to nearest recruiting site
    ~9 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  46. Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

    NCT04221542

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: US Oncology Research Investigational Products Center (Irving, TX)

    Distance to nearest recruiting site
    ~9 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  47. Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

    NCT07145255

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: NEXT, Dallas (Irving, TX)

    Distance to nearest recruiting site
    ~9 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

    NCT07493512

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Next Oncology - Dallas (Irving, TX)

    Distance to nearest recruiting site
    ~9 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  49. Sacral Neuromodulation for Male Overactive Bladder (MOAB)

    NCT06511141

    • Interventional
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Urology Partners of North Texas (UPNT) (Arlington, TX)

    Distance to nearest recruiting site
    ~18 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  50. Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

    NCT07517198

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: START Dallas (Fort Worth, TX)

    Distance to nearest recruiting site
    ~30 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Prostate Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.